Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT05423236 Not yet recruiting - Lung Cancer Clinical Trials

Clinical Characteristics of Lung Cancer in China

Start date: July 1, 2022
Phase:
Study type: Observational

This study is a single-center, real-world and large-population-based retrospective study. In the current study, the investigators not only describe the changes of demographic and basic clinicopathological characteristics of lung cancer during recent years but delineate the correlation between clinicopathological features and common clinical blood tests in such a large population.

NCT ID: NCT05380999 Not yet recruiting - Lung Cancer Clinical Trials

The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection

Start date: May 2022
Phase:
Study type: Observational

This study plan to enroll 852 patients with pulmonary nodules smaller than 3 cm in diameter, whose DNA and RNA will be extracted from mature red blood cells isolated from peripheral blood. The DNA 5-methylcytosine(5-mC) and RNA 2'-O-methylation information will be acquired by NGS and Nm Judge Universally sequencing (NJU-Seq), which will be used to establish models to distinguish patients with benign and malignant nodule in the training group and further evaluated in the validation group. The pathological results will be acquired after surgery or biopsy as standard in the study.

NCT ID: NCT05332171 Not yet recruiting - Lung Cancer Clinical Trials

Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise

Start date: April 2022
Phase: N/A
Study type: Interventional

Cancer treatments usually include surgery, chemotherapy, radiation therapy, hormone therapy, and/or a combination of these methods. These treatments cause many physical and psychological effects that interfere with functional independence, performing activities of daily living, and healthy quality of life. Mostly, depending on cancer and its treatment; Cognitive function, sleep pattern, functional capacity, pain state and bone mineral density are affected. Exercise compliance is the degree to which an individual's behavior is consistent with the health care provider's advice and treatment plan. According to the World Health Organization, compliance is "a measure of a person's behavior (such as following a recommended exercise program, monitoring drug intake, etc.). ) as a response to complying with recommendations deemed appropriate by health care professionals''. In the field of rehabilitation too, compliance is increasingly used in relation to the self-management of patients' health. It has been stated in the studies that the level of compliance with the recommended home exercise is generally low, which limits the benefits of exercise programs.

NCT ID: NCT05321615 Not yet recruiting - Lung Cancer Clinical Trials

Feasibility and Safety of a Wireless Palpator

Palpator
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Evaluation of the ability of the Palpator to detect hidden (occult) lung tumours that cannot be visualized or palpated using the traditional methods of visual inspection, grasper palpation, and VATS ultrasound.

NCT ID: NCT05320458 Not yet recruiting - Lung Cancer Clinical Trials

Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer

Start date: May 2, 2022
Phase: N/A
Study type: Interventional

The aim of our study is to investigate the effects of pulmonary rehabilitation on respiratory tests and quality of life in patients with early and locally advanced NSCLC who received chemotherapy regardless of whether the investigators had undergone surgical treatment.

NCT ID: NCT05279521 Not yet recruiting - Lung Cancer Clinical Trials

The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.

Start date: March 20, 2022
Phase: N/A
Study type: Interventional

This study concluded that lung rehabilitation exercise programs can improve the psychological distress, self-efficacy, quality of life, six-minute walk distance, muscle strength, and reduce the number of hospitalizations for patients with advanced lung cancer.

NCT ID: NCT05203328 Not yet recruiting - Lung Cancer Clinical Trials

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

NCT ID: NCT05179408 Not yet recruiting - Lung Cancer Clinical Trials

Telerehabilitation Following Lung Cancer

Start date: October 1, 2024
Phase: N/A
Study type: Interventional

Lung cancer is the second-most commonly diagnosed cancer among U.S. Veterans. Significant advances have been made in screening and treatment of lung cancer. Longevity following lung cancer has increased. After lung cancer treatment however, many Veterans experience losses in functional capacity and increased symptoms. Rehabilitation services are needed to address these health issues. This study will evaluate a telerehabilitation intervention with Veterans after lung cancer treatment, with goals to improve their function and quality of life, and advance knowledge on strategies to better meet the rehabilitation needs of Veteran lung cancer survivors following treatment. It will also develop the career of a physician researcher to acquire expertise in rehabilitation services for many Veteran lung cancer survivors.

NCT ID: NCT05162235 Not yet recruiting - Lung Cancer Clinical Trials

Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection

ARPL
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

With the popularization of CT screening, the detection rate of small lung nodules has greatly increased. Therefore, the clinical thoracoscopic lung nodule biopsy and sub-lobectomy for radical resection of lung cancer are greatly required. Accurate resection of lung nodule depends on precise localization of pulmonary nodules. However, preoperative CT-guided Hook-wire positioning under local anesthesia, which is the current primary localization method, requires high equipment and expense, and may cause physical and mental trauma to the patient. Augmented reality (AR) is an innovative technology that superimpose a virtual scene into the real environment by fusing images, videos, or computer-generated models with patients during surgical operations. It can visually display the anatomical structures of organs or lesions, which significantly improves surgical efficiency. This project intends to use AR technology to localize the solitary pulmonary nodule (SPN) before surgery, compared with CT-guided Hook-wire localization. Compared with the localization of SPNs under CT guidance, AR-assisted localization technology apparently is less time-consuming and can be performed immediately before surgery under general anesthesia, lessening pain, reduce costs of time and equipment, increase the success rate of sub-lobectomy, and improve the overall efficiency of surgical treatment of pulmonary nodules.

NCT ID: NCT05120050 Not yet recruiting - Lung Cancer Clinical Trials

Clinical Evaluation of ASP Health's Automated ROSE System for Bronchoscopic Applications

Start date: December 2021
Phase:
Study type: Observational

Prospective comparison of cytology slides (bronchoscopically derived fine needle aspiration samples of lymph nodes at the time of rapid intraprocedural on site evaluation) created with the ASP Health's specimen preparation system to slides made by existing conventional methods.